Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 298.5 DKK 0.5% Market Closed
Market Cap: 83.3B DKK

Relative Value

The Relative Value of one GMAB stock under the Base Case scenario is hidden DKK. Compared to the current market price of 1 298.5 DKK, Genmab A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMAB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
66
Median 3Y
11
Median 5Y
13.9
Industry
7.3
Forward
3.2
vs History
53
vs Industry
10
Median 3Y
35.5
Median 5Y
35.5
Industry
23.3
Forward
12.1
vs History
vs Industry
13
Median 3Y
29.5
Median 5Y
33.8
Industry
19.8
vs History
vs Industry
11
Median 3Y
32.3
Median 5Y
35.5
Industry
22.6
vs History
15
vs Industry
38
Median 3Y
6.3
Median 5Y
7.2
Industry
2.7
vs History
73
vs Industry
61
Median 3Y
10.1
Median 5Y
12.6
Industry
7.6
Forward
3.1
vs History
30
vs Industry
64
Median 3Y
7.4
Median 5Y
0
Industry
9.4
vs History
49
vs Industry
12
Median 3Y
30.9
Median 5Y
30.9
Industry
4.7
Forward
9.1
vs History
49
vs Industry
10
Median 3Y
31.9
Median 5Y
31.9
Industry
4.8
Forward
10.1
vs History
vs Industry
14
Median 3Y
25.5
Median 5Y
30.7
Industry
5.3
vs History
vs Industry
10
Median 3Y
27.4
Median 5Y
31.9
Industry
3.8
vs History
52
vs Industry
42
Median 3Y
19.1
Median 5Y
23.7
Industry
5

Multiples Across Competitors

GMAB Competitors Multiples
Genmab A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Genmab A/S
CSE:GMAB
82.3B DKK 10.4 34.7 31.1 32
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 651 194.5 -159 939.1 -194 217.1 -192 000.9
US
Abbvie Inc
NYSE:ABBV
334.3B USD 5.8 80.5 15.3 22.6
US
Amgen Inc
NASDAQ:AMGN
160.4B USD 4.7 27 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
139.1B USD 4.8 23.3 10.1 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.1B USD 10.6 -119.4 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 093.5 -534.2 -581.7 -566.2
AU
CSL Ltd
ASX:CSL
119.8B AUD 5.2 28.6 17.6 22
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.2B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.3B USD 18.4 -160.4 -720.3 -361
P/S Multiple
Revenue Growth P/S to Growth
DK
Genmab A/S
CSE:GMAB
Average P/S: 3 059 397.5
10.4
117%
0.1
FR
Pharnext SCA
OTC:PNEXF
33 651 194.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.6
10%
1.1
US
E
Epizyme Inc
F:EPE
2 093.5
N/A N/A
AU
CSL Ltd
ASX:CSL
5.2
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
18.4
29%
0.6
P/E Multiple
Earnings Growth PEG
DK
Genmab A/S
CSE:GMAB
Average P/E: 34.5
34.7
104%
0.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 939.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.3
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.2 N/A N/A
AU
CSL Ltd
ASX:CSL
28.6
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -160.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Genmab A/S
CSE:GMAB
Average EV/EBITDA: 18
31.1
126%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 217.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.6
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -720.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Genmab A/S
CSE:GMAB
Average EV/EBIT: 22.1
32
121%
0.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 000.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.6
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.2 N/A N/A
AU
CSL Ltd
ASX:CSL
22
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -361 N/A N/A